IL18 and pancreatic ductal adenocarcinoma: Several studies have shown a link between IL18 and cancer, specifically in pancreatic ductal adenocarcinoma (PDAC), where high levels of IL18 are associated with increased mortality and poor disease outcomes (Yamanishi et al., 2023).